<?xml version="1.0" encoding="UTF-8"?>
<p>For rapid diagnosis, Abbott and LabCorp looked into mass-producing antibody tests [
 <xref rid="B43-diagnostics-10-00409" ref-type="bibr">43</xref>]. These tests focus on testing for Immunoglobulin G (IgG) antibodies because its responses relate to adaptive immunity and have immunological memory of previous virus encounters. The presence of these IgG antibodies can identify what specific antigen it has a high affinity for, and the previous virus is encountered [
 <xref rid="B44-diagnostics-10-00409" ref-type="bibr">44</xref>]. In the context of COVID-19, the testing provides information on whether that patient was previously infected and whether immunity was detected or not.
</p>
